Shots:
Rallybio has entered into a definitive agreement to acquire Avenzo through a merger transaction, after which the combined company will operate under the name Avenzo Therapeutics & is expected to trade on Nasdaq under the ticker symbol "AVZO"
As per the deal, Avenzo shareholders will receive newly issued Rallybio shares based on the companies’…
Shots:
Martin shared his views on the appointment of Jonathan I. Lieber as the CFO of Rallybio. Martin spoke about Jonathan's educational background and experience while talking to PharmaShots' team
He also talked about how Jonathan I. Lieber’s expertise in finance, capital raising, long-range strategic planning, operations, and investor relations can contribute to the long-term…

